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ABSTRACT 
Objective: The objective of this selective EBM review is to determine whether or not the 
use of yoga helps to improve fatigue in patients with Multiple Sclerosis (MS).  
Study Design: Review of three randomized controlled trials (RCTs) published between 
2004-current, all in the English language.  
Data Sources: Three randomized controlled trials (RCTs), all of which evaluate the 
effectiveness of yoga compared to a control group that was asked not to change their 
exercise habits as they pertain to fatigue. All studies were found using PubMed and 
EBSCOhost.  
Outcomes Measured: Each of the three articles analyzed the effects of yoga therapy on 
improving fatigue. The Fatigue Severity Scale (FFS), Modified Fatigue Impact Scale 
(MFIS), and Multi-dimensional Fatigue Inventory (MFI) were the questionnaires used to 
measure fatigue.  
Results: One study found that yoga significantly reduced fatigue in MS patients. One 
study approached statistical significance in support for yoga as an effective therapy. One 
study was inconclusive.    
Conclusions: Evidence is inconclusive. Future studies should focus on long-term effects 
of yoga and include subjects with more than minimal gait impairment.  
Keywords: “multiple sclerosis” “yoga” “fatigue”  
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INTRODUCTION 
Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the central nervous 
system that results in many symptoms including mobility limitation, bowel and bladder 
dysfunction, and fatigue. MS is the most common disabling neurological disease of young 
adults.1 Fatigue is a common symptom of MS, occurring in about 80% of people.2 The patient 
with MS-related fatigue may feel constantly tired or may be easily fatigued from mental or 
physical exertion. Fatigue is one of the major barriers restricting people with MS from working.2 
Since MS affects approximately 400,000 people in the US with a prevalence of approximately 90 
per 100,000, addressing fatigue may have a large impact on quality of life for MS patients.3   
Multiple sclerosis is often an expensive disease and financial problems are compounded 
if the patient is no longer able to work due to fatigue. Total average costs are estimated at 
$47,215 per patient per year for those using disease modifying drugs (DMDs) to treat MS.4 It is 
unknown how many healthcare visits per year MS patients make to manage their MS, but it is 
thought that patients with MS require more visits per person than all but a handful of other 
diagnostic groups.5 This can be attributed to the multi-disciplinary approach that must be taken 
when treating a patient with MS. Most patients require more than DMDs alone to manage their 
symptoms. Other therapies include complex and expensive pharmacological agents, 
multidisciplinary medical and rehabilitation services, and assistive technology.5 
While there are still many unknowns about MS, it is widely believed to be an 
autoimmune attack on the body’s own cells. The myelin sheath, the fatty protective covering that 
surrounds nerves and aids in nerve signal conduction, is damaged, causing nerve signals to slow 
down or stop. The exact cause of the disease is still unknown but there appears to be genetic and 
environmental factors, like viruses, involved. MS is diagnosed by ruling out other conditions.6 
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Symptoms vary because nerves in any part of the brain or spinal cord can be damaged, causing 
the location and severity of each attack to be different.  Common presenting symptoms include 
muscle weakness, problems moving arms or legs, numbness, tingling, or burning sensation, loss 
of balance, incontinence, double vision or vision loss, painful muscle spasms, dizziness, 
depression, erectile dysfunction, or fatigue.6 
Typically MS is treated using disease modifying drugs (DMDs). For acute exacerbations 
(“attacks”), corticosteroids may be used. Other medications are taken on a regular basis to lower 
the rate of relapses and reduce the rate of formation of new lesions in relapsing-remitting MS. 
These include beta interferons, glatiramer acetate (Copaxone), dimethyl fumarate (Tecfidera), 
fingolimod (Gilenya), teriflunomide (Aubagio), natalizumab (Tysabri), and mitoxantrone 
(Novantrone). Physical therapy, muscle relaxants, and medications to reduce fatigue are often 
used to manage symptoms.7 
Fatigue is often a difficult symptom to treat. Medications such as amantadine and 
modafinil are commonly prescribed to treat MS-related fatigue. Yoga is being proposed as an 
alternative therapy to medication for the reduction of fatigue due to MS. Yoga can be less 
expensive than medication and carries the added benefit of potentially improving other deficits 
caused by MS such as impaired balance and mobility limitations.  
 
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not “Is yoga 
effective in reducing fatigue in patients with Multiple Sclerosis?” 
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METHODS 
The studies in this systematic review included only adults with multiple sclerosis (MS). 
Each of the studies compares yoga therapy to participants’ normal exercise routines in adults 
with MS and analyzed yoga’s effects on improving fatigue. Included in this analysis was a 
randomized controlled trial comparing yoga three times per week for eight weeks to a control 
group in which subjects’ followed their own routine treatment/exercise program. The second 
randomized controlled trial compared yoga once per week for ten weeks to a control group that 
was asked not to change their regular exercise habits. The third randomized controlled trial 
compared yoga once per week for six months to a waiting list control group who was asked to 
maintain their usual exercise program if they had one. The outcomes measured the efficacy of 
yoga in reducing fatigue using subjective questionnaires including the Fatigue Severity Scale 
(FFS), the Modified Fatigue Impact Scale (MFIS), and the Multideminensional Fatigue 
Inventory (MFI).  
The data sources collected for this EBM review were found through researching PubMed 
and EBSCOhost from December 2013 through December 2014. The keywords used in the 
searches included “yoga” and “fatigue” and “Multiple Sclerosis.” All articles were written in 
English and published in peer-reviewed journals. The articles were chosen based on their 
relevant outcomes to the topic and the importance of their information for patients. Each article 
was carefully selected to ensure it addressed a POEM (patient oriented evidence that matters), in 
this case fatigue, and was within the Physician Assistant scope of practice. Articles were also 
selected based on type of study (randomized controlled trial). Included in these studies were 
subjects with physician-diagnosed Multiple Sclerosis over the age of 18 who scored 6.0 or less 
on the Expanded Disability Status Scale, in other words, those who required at most unilateral 
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support to walk outdoors. Persons with MS were excluded if they had a previous relapse or 
began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, 
or had a comorbidity that severely impacted their ability to safely participate in exercise. 
Specifically, those who had cardiovascular disease, liver or kidney failure, symptomatic lung 
disease, diabetes, thyroid disorders, gout or orthopedic limitations, or were addicted to cigarettes, 
alcohol, or drugs were also excluded. The summary of statistics reported or used included p-
values, mean change from baseline, paired t-tests, Turkey test, and analysis of variance 
(ANOVA). The demographics of each study can be found in Table 1 below.  
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Table 1: Demographics and characteristics of included studies 
Study Type # 
Pts 
Age 
(yrs) 
Inclusion 
Criteria 
Exclusion Criteria  W/D Interventions 
Ahmadi 
(2013)8 
RCT 21 19-
54 
Physician 
diagnosed 
MS with a 
Expanded 
Disability 
Status Scale 
(EDSS) score 
of 1.0-4.0 
Cardiovascular 
disease, liver or 
kidney failure, 
symptomatic lung 
disease, diabetes, 
thyroid disorders, 
gout, orthopedic 
limitations, 
pregnant, or 
addicted pts 
(cigarettes, drugs, 
alcohol) 
0 60-70 
minute yoga 
class, three 
times per 
week for 8 
weeks 
Garrett 
(2013)9 
RCT 148 >18 Pts had 
clinically 
diagnosed 
MS and used 
at most 
unilateral 
support to 
walk 
outdoors  
Pts with previous 
relapse or began 
steroid therapy in 
the 12 weeks prior 
to the first 
assessment, were 
pregnant, or had a 
comorbidity that 
severely impacted 
their ability to 
safely participate in 
exercise. 
36 60 minute 
yoga class, 
once per 
week for 10 
weeks 
Oken 
(2004)10 
RCT 42 >18 Pts had 
clinically 
diagnosed 
MS, and 
EDSS less 
than or equal 
to 6.0 
Insulin-dependent 
diabetes, 
uncontrolled 
hypertension, liver 
or kidney failure, 
symptomatic lung 
disease, 
alcoholism/drug 
abuse, symptoms or 
signs of CHF, 
ischemic heart 
disease, 
symptomatic 
valvular disease or 
corrected visual 
acuity worse than 
20/50 binocularly. 
6 90 minute 
yoga class, 
once per 
week for 6 
months 
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OUTCOMES MEASURED 
The outcome measured is improvement in fatigue. Ahmadi et al8 measured improvement 
in fatigue using a 9-item self-reported questionnaire called the Fatigue Severity Scale (FFS) 
which is designed to assess the severity of fatigue and its effects on a person’s activities and 
lifestyle. Garrett et al9 measured fatigue using the 21-item Modified Fatigue Impact Scale 
(MFIS), which is a modified version of the Fatigue Impact Scale, designed based on interviews 
with MS patients concerning how fatigue impacts their lives. Oken et al10 measured fatigue 
outcomes using the Multi-Dimensional Fatigue Inventory (MFI), a 20-item self-reported 
questionnaire designed to measure fatigue. Questionnaires were completed at baseline and after 
the yoga intervention. The fatigue measurements were analyzed using p-values, mean change 
from baseline, paired t-tests, independent t-tests, Turkey test, and analysis of variance (ANOVA).  
RESULTS  
Results of three randomized controlled trials are evaluated in this systematic review. All 
studies provided continuous data that could not be converted to dichotomous format. Test 
statistics reported included p-values, confidence intervals, and mean change from baseline.  
 Ahmadi et al8 compared an 8 week program of Hatha yoga (n=11) to a control group 
where participants followed their routine exercise program (n=10). Included in the yoga group 
were female patients with physician-diagnosed Multiple Sclerosis over the age of 18 who scored 
1.0 to 4.0 on the Expanded Disability Status Scale. Patients using MS disease modifying drugs 
were also included. Additionally, participants were required to be able to walk on the treadmill 
with or without hand support (without human assistance) and be able to walk at a constant speed 
on a treadmill for five minutes. See Table 1 for exclusion criteria. The yoga classes were 60-70 
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minutes in duration and three sessions per week. The yoga teacher was familiar with problems 
common to those with MS so breathing techniques and supported poses were utilized. Attrition 
rate was 0%. Paired t-tests were used to determine within-group differences in fatigue. Fatigue 
levels were significantly lower during post-test than pre-test in the yoga group by 38.69% 
(p=0.01) with a negligible increase of 1.43% (p=0.82) in the control group. The mean difference 
in FFS score between the yoga and control groups was 1.59 (p = 0.03), determined using Turkey 
Test. See Table 2 below for the results.  
Table 2. Interventional Baseline Changes in FFS Score at 8 weeks 
 Yoga group (n=11) Control group (n=10) 
Mean difference in FFS score 
between pre- and post-
intervention  
38.69% decrease 
(p = 0.01*) 
 
1.43% increase  
(p = 0.82) 
 
Mean difference in FFS score 
between groups (yoga vs. control) 
1.59 (p=0.03*) 
 
 
 The Garrett et al9 study was an assessor-blind RCT that assessed the effects a 10 week 
yoga program (n=77) had on fatigue compared to a control group (n=71) asked not to change 
their exercise habits. Participants were physician-diagnosed MS patients over the age of 18 who 
used at the most unilateral support to walk outdoors. Participants were excluded if they had a 
previous relapse or began steroid therapy in the 12 weeks prior to participating in the first 
assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely 
participate in exercise. The yoga classes were conducted in groups of eight subjects for 60 
minutes per week, once per week, for 10 weeks. Yoga classes included breathing exercises, 
range of motion or stretching exercises, and relaxation. Adherence was fair, with participants 
allocated to the yoga intervention attending a mean of 7.8 of the 10 classes. This study had an 
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attrition rate of 22.93% but the reasons for attrition were similar across groups and those who 
dropped out were not significantly different from those who remained in the trial. Fatigue levels 
were measured using MFIS score (0-84). Paired t-tests were used to determine within-group 
changes.  Fatigue levels in the yoga intervention group decreased by 5.8 with a 95% CI (-9.2 – - 
2.4) p value <0.01 from pre-test to post-test on MFIS. Comparatively, in the control group, 
fatigue levels decreased by 1.1 (-4.4, 2.3) p = 0.512. Change in fatigue between the yoga and 
control groups was analyzed using independent t-tests on the change scores. The change in 
fatigue was shown to approach statistical significance in the yoga group compared to the control 
group (p=0.05). See Table 3 below for the results.  
Table 3. Interventional Baseline changes in MFIS Total Score at 12 weeks 
 Yoga group (n=63) Control group (n=49) 
Mean difference (95%CI) in 
MFIS score between pre- 
and post-intervention 
-5.8 (-9.2 – -2.4) -1.1 (-4.5, 2.3) 
P-value (within group) <0.01* 0.512 
P value (yoga vs. control)  0.05* 
*p < 0.05 
The study conducted by Oken et all0 compared a six-month yoga intervention (n=22) to a 
waiting-list control group (n=20). The waiting list group was told they could enroll in either a 
yoga or exercise class after that 6-month period at no cost. A neurologist reviewed medical 
records for diagnostic criteria for MS. Only subjects with an EDSS score of 6.0 or less (i.e., able 
to walk 100 meters with at most unilateral support) were allowed to enroll. Subjects were 
excluded if they had insulin-dependent diabetes, uncontrolled hypertension, liver or kidney 
failure, symptomatic lung disease, alcoholism/drug abuse, symptoms or signs of CHF, ischemic 
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heart disease, symptomatic valvular disease or corrected visual acuity worse than 20/50 
binocularly. Also excluded were those who performed yoga or tai-chi in the last 6 months or 
were regularly performing aerobic exercise more than 30 minutes per day. The yoga classes were 
90 minutes in duration once per week for 6 months. Iyengar yoga was performed. Yoga classes 
included supported poses and relaxation. Daily home practice was strongly encouraged. 
Attendance rate for weekly yoga class was 68% and home practice occurred on 51% of non-class 
days. Fatigue was assessed using the Multidimensional Fatigue Inventory (MFI) at baseline and 
6 months. The authors calculated mean within-group MFI scores with standard deviation for 
each group. Change from baseline or between-group differences were not calculated, causing the 
study to be inconclusive in answering if yoga is effective in treating fatigue. Despite this, the 
MFI score at the end of the yoga intervention was significantly lower than at baseline (p<0.01). 
See Table 4 for results.  
Table 4: MFI Scores Measuring General Fatigue  
 Yoga (n=22) Wait list (n=20) 
Pre-intervention MFI 
score (SD) 
14.7 ± 3.3 15.1 ± 3.4 
Post-intervention MFI 
score (SD) 
13.0 ± 2.9* 14.9 ±3.0 
* p < 0.01 
 No adverse events related to the intervention were reported. Oken et al10 was the only 
study that discussed adverse events, which included three for unrelated surgeries; one MS 
exacerbation in the yoga group; and one low back pain related to an auto accident. Yoga is a very 
safe intervention with few to zero adverse events associated with its practice.  
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DISCUSSION  
 Multiple Sclerosis is the most common disabling neurological disease of young adults.1 
Disease modifying drugs are often helpful in slowing the progression of the disease and reducing 
exacerbations but they do not improve the potentially debilitating fatigue that often accompanies 
MS. Medications such as amantadine (Symmetrel) and modafinil (Provigil) are the most 
commonly prescribed medications used to treat MS-related fatigue.2 Many patients have begun 
to shift away from using medication to manage their symptoms, looking instead for alternative 
therapies such as yoga. Ahmadi et al8 showed yoga to significantly improve fatigue compared to 
control group. The data approached statistical significance in Garrett et al9 so we are unable to 
say the study conclusively supported yoga as an effective treatment for fatigue. Oken et al10 did 
not directly compare the yoga group to the control group so it is inconclusive. Despite the 
inconclusive evidence, yoga is widely accessible and the expenses may be reimbursed or 
discounted by some insurance companies.11 
 All three of the studies limited enrollment to persons with mild gait impairment. Ahmadi 
et al8 was forced to limit their study to women due to the exclusion criteria and the limited 
number of men available to participate. Ahmadi et al8 was also limited by a small sample size – 
only eleven participants in the yoga group and ten in the control group. The study by Garret et al9 
may have included a selection bias because subjects were asked to self-refer to the study, so the 
results may not be valid for those who are not as positively predisposed to health-promoting 
exercise behaviors. Oken et al10 was limited by the mostly female group of participants and 
acknowledges other potential mechanisms of action that could account for the improvement in 
fatigue such as socialization during yoga classes, placebo effect, and self-efficacy effect.  
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 There are barriers to MS patients practicing yoga. Some aspects of a typical yoga class 
are not designed with MS patients in mind and may even be contraindicated in MS. For instance, 
MS symptoms can be exacerbated by heat.12 Ahmadi et al8 kept the yoga practice room around 
23-26 °C (73.4 – 78.8 °F) so that MS symptoms would not be aggravated. Also, two of the three 
studies reviewed used supported poses during yoga practice to aid with balance but most 
community yoga classes do not employ supported poses. MS patients attending a regular yoga 
class may have difficultly with some of the unsupported poses due to impaired balance and 
fatigue. It is important for patients with MS to find an instructor who is well educated in pose 
modifications.  
CONCLUSIONS 
 This systematic review of three randomized controlled trials comparing yoga therapy to a 
control group asked not to change their exercise habits shows that the effects of yoga are 
inconclusive in reducing MS-related fatigue. The Ahmadi et al8 and Oken et al10 studies were 
fairly small so larger studies and studies analyzing long-term effects of yoga therapy on fatigue 
may be more generalizable and advantageous to patients with MS.  Also, all three studies 
reviewed were limited to those with minimal gait dysfunction. Future studies should include 
patients with increased gait dysfunction to broaden the spectrum of patients able to benefit from 
yoga therapy. 
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